About us

Leukaemia Care is the UK’s leading leukaemia charity. For over 50 years, we have been dedicated to ensuring that everyone affected receives the best possible diagnosis, information, advice, treatment and support.

Contact us

For all general enquiries, information about events, fundraising or anything else, including requests for resources get in touch with us today using any of the details below.

Who we are and what we do

Leukaemia Care is the UK’s leading leukaemia charity.

Our strategic plan

We exist to improve the lives of everyone affected by leukaemia, MDS and MPN. Over the last 50 years, we have come a long way, but there is more to be done.

Our Trustee Board

Here at Leukaemia Care we have a small but dedicated trustee board. Find out more about each member here…

Meet our Patrons and Ambassadors

Our Patrons help to raise awareness of our charity, blood cancers and issues facing patients and their families. We are grateful to them all for their wonderful support.

Vacancies

Find out more about the latest vacancies at Leukaemia Care.

Volunteering opportunities

Contribute your time and expertise to enhance the lives of those impacted by leukaemia through volunteering with us.

Privacy policy

The Leukaemia Care privacy policy as of 6th March 2024

Press and media centre

Looking to write an article about Leukaemia? We've got some of the facts and statistics that you can quote.

Annual accounts and reports

View our annual reports and financial statements.

Fundraising promise

Supporters drive everything we do at Leukaemia Care. It’s thanks to your generosity that we are able to support so many leukaemia patients, read on to learn more about our fundraising promise.

Our complaints procedure

Read more about our complaints procedure below.

CAR-T information hub

CAR-T (Chimeric Antigen Receptor) cell therapy is a type of leukaemia treatment. If you are about to or are undergoing CAR-T treatment, get the support you need from Leukaemia Care.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

November 11th

Additional treatment for AML patients now available in Scotland

Leukaemia Care is pleased to announce that newly diagnosed acute myeloid leukaemia (AML) patients with a FLT3 mutation now have access to quizartinib, in combination with chemotherapy, thanks to a decision made by the Scottish Medicines Consortium (SMC) today. ...

October 31st

Leukaemia Care’s response to the 2024 Autumn Budget

"We welcome the increase in the NHS budget. However..." - Colin Dyer, Chief Executive at Leukaemia Care shares the charity's response....

October 22nd

NEW NHS treatment option for myelofibrosis patients

Certain patients with myelofibrosis will have access to fedratinib to treat myelofibrosis, thanks to a decision made by the National Institute for Health and Care Excellence (NICE). ...